These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38217028)

  • 1. Bullous pemphigoid and diabetes mellitus: a systematic review and meta-analysis.
    Jiirasutat N; Pongchareon P; Weschawalit S
    Int J Dermatol; 2024 May; 63(5):572-579. PubMed ID: 38217028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of diabetes mellitus in bullous pemphigoid patients in the absence of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis.
    Guo W; Rathi S; Marquez J; Smith H; Kuruvilla A; Tonnesen MG; Salvemini JN
    Arch Dermatol Res; 2023 Oct; 315(8):2207-2213. PubMed ID: 36867222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of bullous pemphigoid and comorbid health conditions: a case-control study.
    Lee S; Rastogi S; Hsu DY; Nardone B; Silverberg JI
    Arch Dermatol Res; 2021 Jul; 313(5):327-332. PubMed ID: 32647978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Medication Use and Bullous Pemphigoid: A Systematic Review and Meta-analysis.
    Liu SD; Chen WT; Chi CC
    JAMA Dermatol; 2020 Aug; 156(8):891-900. PubMed ID: 32584924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
    Zhou Q; Xiong Z; Yang D; Xiong C; Li X
    PLoS One; 2023; 18(11):e0295135. PubMed ID: 38033098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of dipeptidyl peptidase IV inhibitors and other risk factors with bullous pemphigoid in patients with type 2 diabetes mellitus: A retrospective cohort study.
    Guo JY; Chen HH; Yang YC; Wu PY; Chang MP; Chen CC
    J Diabetes Complications; 2020 Mar; 34(3):107515. PubMed ID: 31932172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of diabetes mellitus on medical complication and mortality rates among inpatients with bullous pemphigoid.
    Patel S; Ahsanuddin S; Cadwell JB; Lambert WC
    Ir J Med Sci; 2022 Aug; 191(4):1669-1675. PubMed ID: 34402030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between bullous pemphigoid and psoriasis: Systematic review and meta-analysis of case-control studies.
    Phan K; Goyal S; Murrell DF
    Australas J Dermatol; 2019 Feb; 60(1):23-28. PubMed ID: 30141189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of venous thromboembolism in patients with bullous pemphigoid: A systematic review and meta-analysis.
    Ungprasert P; Wijarnpreecha K; Thongprayoon C
    Indian J Dermatol Venereol Leprol; 2018; 84(1):22-26. PubMed ID: 29185440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Dipeptidyl Peptidase 4 Inhibitor Use With Risk of Bullous Pemphigoid in Patients With Diabetes.
    Lee SG; Lee HJ; Yoon MS; Kim DH
    JAMA Dermatol; 2019 Feb; 155(2):172-177. PubMed ID: 30624566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis.
    Lai YC; Yew YW; Lambert WC
    J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2007-2015. PubMed ID: 27599898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.
    Chen X; Zhang Y; Luo Z; Wu Y; Niu T; Zheng J; Xie Y
    PLoS One; 2022; 17(4):e0264705. PubMed ID: 35427358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis.
    Atzmony L; Mimouni I; Reiter O; Leshem YA; Taha O; Gdalevich M; Hodak E; Mimouni D
    J Am Acad Dermatol; 2017 Oct; 77(4):691-699. PubMed ID: 28645646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients.
    Teixeira VB; Cabral R; Brites MM; Vieira R; Figueiredo A
    An Bras Dermatol; 2014; 89(2):274-8. PubMed ID: 24770504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cross-Sectional Study Comparing the Prevalence of Bullous Pemphigoid Autoantibodies in 275 Cases of Type II Diabetes Mellitus Treated With or Without Dipeptidyl Peptidase-IV Inhibitors.
    Izumi K; Nishie W; Beniko M; Shimizu H
    Front Immunol; 2019; 10():1439. PubMed ID: 31297116
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between bullous pemphigoid and atopic dermatitis: a population-based case-control study in Taiwan.
    Wu PC; Wu CY; Lyu YS; Chang YT; Wu CY
    Arch Dermatol Res; 2023 Apr; 315(3):419-427. PubMed ID: 35834038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase-4 inhibitor treatment and the risk of bullous pemphigoid and skin-related adverse events: A systematic review and meta-analysis of randomized controlled trials.
    Yang W; Cai X; Zhang S; Han X; Ji L
    Diabetes Metab Res Rev; 2021 Mar; 37(3):e3391. PubMed ID: 32741073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrotizing Fasciitis-Severe Complication of Bullous Pemphigoid: A Systematic Review, Risk Factors, and Treatment Challenges.
    Stojičić M; Jurišić M; Marinković M; Karamarković M; Jovanović M; Jeremić J; Jović M; Vlahović A; Jovanović M; Radenović K; Jovićević N; Vasović D
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109703
    [No Abstract]   [Full Text] [Related]  

  • 20. The association between bullous pemphigoid and comorbidities: a case-control study in Moroccan patients.
    Titou H; Kerrouch H; Frikh R; Hjira N
    Acta Dermatovenerol Alp Pannonica Adriat; 2022 Mar; 31(1):7-11. PubMed ID: 35339128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.